Role of the SNK-SPAR pathway in the development of Alzheimer's disease
✍ Scribed by Xiaoyang Gong; Xiaoguang Lu; Libin Zhan; Hua Sui; Xin Qi; Zhenghong Ji; Xinping Niu; Li Liu
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 663 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1521-6543
- DOI
- 10.1002/iub.308
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Alzheimer's disease (AD) is characterized by the presence of senile plaques and neurofibrillary tangles in the brain. The beta‐amyloid peptide (Aβ) is the primary constituent of the senile plaques, and has been proposed to be a key contributor to the neurodegeneration observed in AD. The molecular mechanisms underlying dendritic spine damage that is induced by Aβ toxicity in AD patients remain largely unknown. It has been suggested previously that the SNK‐SPAR signaling pathway is involved in activity‐dependent remodeling of synapses. The relationship between the SNK‐SPAR pathway and Aβ‐induced excitotoxicity, however, is poorly understood. The present study investigated the effects of bilateral intrahippocampal injection of Aβ peptide 1–40 (Aβ~1–40~) on learning and memory in the rat, and explored the mechanisms underlying the effects of this injection. We reported that bilateral injection of Aβ~1–40~ in rats resulted in impaired performance in the step‐down passive avoidance and Morris water maze tasks. Then we examined mRNA and protein expression levels in the different brain regions one week after injection with Aβ~1–40~ and found that the SNK‐SPAR signaling pathway was possibly involved in dendritic spine damage in the different brain regions of Aβ‐treated rats. These results demonstrate that the SNK‐SPAR pathway may possibly play a crucial role in Aβ‐induced excitotoxic damage in the central nervous system by regulating synaptic stability. © 2010 IUBMB IUBMB Life, 62(3): 214–221, 2010
📜 SIMILAR VOLUMES
## Abstract Abnormalities in mitochondrial function relate to the spectrum of pathological changes seen in Alzheimer's disease. Here we review the causes and consequences of mitochondrial disturbances in Alzheimer's disease as well as how this information might impact on therapeutic approaches to t
A number of important neurotransmitter deficiencies have been described in Alzheimer's disease, the commonest cause of dementia in people at all ages. Particularly marked is the depletion of acetylcholine, and a number of treatments have been developed which are aimed at correcting this biochemical
## Abstract Researchers have for some time appreciated the role of the neurotransmitter acetylcholine in Alzheimer's disease, and have realized the development of a number of acetylcholinesterase inhibitors. Bridging and dynabridging studies have played an important role in the development of these
## Abstract Alzheimer's disease (AD) is a dementing neurodegenerative disorder without a cure. The abnormal parenchymal accumulation of β‐amyloid (Aβ) is associated with inflammatory reactions involving microglia and astrocytes. Increased levels of Aβ and Aβ deposition in the brain are thought to c